Anticancer effects of Huaier are associated with down-regulation of P53

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2251-2254

  Xu, Xiao ^a   Wei, Qiang ^a   Wang, Kai ^a   Ling, Qi ^a   Xie, Haiyang ^a   Zhou, Lin ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Animal model; Anticancer effect; Hepatocellular carcinoma; Huaier

Indexed keywords

AFP PROTEIN, RAT; ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; DIETHYLNITROSAMINE; MESSENGER RNA; PROTEIN P53;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHINESE MEDICINE; DOWN REGULATION; DRUG EFFECT; FUNGUS; GENETICS; LIVER TUMOR; MALE; METABOLISM; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; SURVIVAL RATE;

ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIETHYLNITROSAMINE; DOWN-REGULATION; FUNGI; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MEDICINE, CHINESE TRADITIONAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866296888     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Beckman KB, Ames BN (1997). Oxidative decay of DNA. J Biol Chem, 272, 19633-19636.
2. Boisvert FM, Lamond AI (2010). p53-Dependent subcellular proteome localization following DNA damage. Proteomics, 10, 4087-4097
3. Cha C, Fong Y, Jarnagin WR, et al (2003). Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg, 197, 753-758.
4. Chipuk JE, Green DR (2006). Dissecting p53-dependent apoptosis. Cell Death Differ, 13, 994-1002.
5. El-Serag HB (2002). Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol, 35, S72-S78.
6. Jadon A, Bhadauria M, Shukla S (2007). Protective effect of Terminalia belerica Roxb. and gallic acid against carbon tetrachloride induced damage in albino rats. J Ethnopharmacol, 109, 214-218.
7. Jagan S, Ramakrishnan G, Anandakumar P, et al (2008). Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma. Mol Cell Biochem, 319, 51-59.
8. Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics. CA Cancer J Clin, 57, 43-66.
9. Liang G, Wen T, Yan L, et al (2009). A prospective randomized comparison of continuous hemihepatic with intermittent total hepatic inflow occlusion in hepatectomy for liver tumors. Hepatogastroenterology, 56, 745-750.
10. Libbrecht L, Severi T, Cassiman D, et al (2006). Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol, 30, 1405-1411.
11. Llovet JM, Bruix J (2008). Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol, 48, S20-S37.
12. Marengo B, De Ciusis C, Ricciarelli R, et al (2010). DNA oxidative damage of neoplastic rat liver lesions. Oncol Rep, 23, 1241-1246.
13. Miyake K, Miyake N, Kondo S, et al (2009). Seasonal variation in liver function tests: a time-series analysis of outpatient data. Ann Clin Biochem, 46, 377-384.
14. Momota H, Narita Y, Matsushita Y, et al (2010). p53 abnormality and tumor invasion in patients with malignant astrocytoma. Brain Tumor Pathol, 27, 95-101.
15. Ozturk H, Gezici A, Ozturk H (2006). The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusioninduced oxidative stress in rats. Hepatol Res, 34, 76-83.
16. Ramakrishnan G, Augustine TA, Jagan S, et al (2007). Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Exp Oncol, 29, 39-44.
17. Ramakrishna G, Raghavendran HR, Vinodhkumar R, et al (2006). Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem Biol Interact, 161, 104-114.
18. Ren FY, Piao XX, Jin AL (2006). Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J. Gastroenterol, 12, 4656-4659.
19. Squire RA, Levitt MH (1975). Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res, 35, 3214-323.
20. Vogelstein B, Lane D, Levine AJ (2000). Surfing the p53 network. Nature, 408, 307-310.
21. Xu X, Ke QH, Shao ZX, et al (2009). The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci, 54, 385-388.
22. Yoshiji H, Nakae D, Kinugasa T, et al (1991). Inhibitory effect of dietary iron deficiency on the induction of putative preneoplastic foci in rat liver initiated with diethylnitrosamine and promoted by phenobarbital. Br J Cancer, 64, 839-842.
23. Yuen MF, Hou JL, Chutapurri A (2009). Asia Pacific Working Party Prevention of Hepatocellular Carcinoma. Hepatocellular carcinoma in the Asia Pacific Region. J Gastroenterol Hepatol, 24, 346-353.
24. Zhang N, Kong X, Yan S, et al (2010). Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci, 101, 2375-2383.
25. Zheng SS, Xu X, Liang TB, et al (2005). Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases. Zhonghua Wai Ke Za Zhi, 43, 450-454.
26. Zinkin NT, Grall F, Bhaskar K, et al (2008). Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res, 14, 470-477.